Press

MagicMed Industries Inc. announced the closing of its upsized and oversubscribed previously announced private placement of units of the company for aggregate gross proceeds of approximately $8.1M.

Tryp Therapeutics Inc. announced the successful closing of its previously announced initial public offering.

Numinus Wellness Inc. has completed the first legal extraction of Psilocybe mushrooms in Canada by a public company for research and development purposes.

Ehave, Inc. announced KetaDASH, an Intravenous (IV) based, home delivery platform for patients who have been prescribed Ketamine.

PharmaTher Inc. announced that it has filed a provisional patent outlining the potential for novel combinations of psilocybin and U.S. Food and Drug Administration approved drugs to treat neurological disorders.